Anika Therapeutics Inc (NASDAQ:ANIK)

38.94
Delayed Data
As of May 18
 -0.09 / -0.23%
Today’s Change
30.91
Today|||52-Week Range
69.81
-27.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues105.6M93.0M103.4M113.4M
 
 
 
 
 
Cost of Goods Sold16.2M17.3M20.3M23.1M
 
 
 
 
 
Depreciation And Amortization4.7M3.8M3.7M4.3M
 
 
 
 
 
 
Operating ExpensesGross Income84.7M71.9M79.4M86.1M
 
 
 
 
 
General Expenses23.2M23.8M28.7M40.3M
 
 
 
 
 
Research And Development8.1M9.0M10.7M18.8M
 
 
 
 
 
Total Operating Expenses44.1M44.9M52.8M67.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income61.4M48.1M50.6M45.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income61.5M48.3M50.9M46.2M
 
 
 
 
 
Income Taxes-23.2M-17.5M-18.3M-14.4M
 
 
 
 
 
Net Income38.3M30.8M32.5M31.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.7M14.9M14.7M14.6M
 
 
 
 
 
Shares To Calculate EPS Diluted15.3M15.3M15.1M15.1M
 
 
 
 
 
 
Earnings Per ShareEPS$2.51$2.01$2.15$2.11
 
 
 
 
 
EPS Diluted$2.51$2.01$2.15$2.11